Sudhakar Manda
Impact in
- Toxicology top 5%
- Biotechnology top 10%
- Marine Sponges and Natural Products
Papers in
-
- Ubiquitin and proteasome pathways 3
- Angiogenesis and VEGF in Cancer 1
-
- Chemical synthesis and alkaloids 2
- Co-authors
- Sandip B. Bharate (11 shared papers)Ram A. Vishwakarma (9 shared papers)Prashant Joshi (4 shared papers)Nagaraju Mupparapu (2 shared papers)Shashi Bhushan (3 shared papers)Santosh Kumar Guru (3 shared papers)Narsaiah Battini (1 shared paper)Ajay Kumar (3 shared papers)
- Journals
- MedChemComm (2 papers)Journal of Medicinal Chemistry (1 paper)European Journal of Medicinal Chemistry (1 paper)Chemico-Biological Interactions (1 paper)Molecules (1 paper)
- Partner nations
- IndiaUnited StatesUnited Kingdom
In The Last Decade
Sudhakar Manda
12 papers receiving 499 citations
Peers
Comparison fields: 5 of 65
- Toxicology 39
- Biotechnology 82
- Organic Chemistry 214
- Pharmacology 87
- Molecular Biology 253
Countries citing papers authored by Sudhakar Manda
This map shows the geographic impact of Sudhakar Manda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sudhakar Manda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sudhakar Manda more than expected).
Fields of papers citing papers by Sudhakar Manda
This network shows the impact of papers produced by Sudhakar Manda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sudhakar Manda. The network helps show where Sudhakar Manda may publish in the future.
Co-authors
The 25 scholars most cited alongside Sudhakar Manda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 85 | |
| 2 | 2015 | 63 | |
| 3 | 2017 | 61 | |
| 4 | 2015 | 57 | |
| 5 | 2012 | 50 | |
| 6 | 2014 | 43 | |
| 7 | 2015 | 39 | |
| 8 | 2012 | 39 | |
| 9 | 2014 | 37 | |
| 10 | 2020 | 17 | |
| 11 | 2016 | 6 | |
| 12 | 2003 | 6 | |
| 13 | 2025 | 0 |
About Sudhakar Manda
Sudhakar Manda is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Oncology and Cell Biology, having authored 13 papers that have together received 503 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Microtubule and mitosis dynamics (2 papers), Cancer-related Molecular Pathways (2 papers), Chemical synthesis and alkaloids (2 papers), Angiogenesis and VEGF in Cancer (1 paper), Alzheimer's disease research and treatments (1 paper) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Toxicology (39 citations), Biotechnology (82 citations), Organic Chemistry (214 citations), Pharmacology (87 citations) and Molecular Biology (253 citations). Sudhakar Manda has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Sandip B. Bharate, Ram A. Vishwakarma, Prashant Joshi, Nagaraju Mupparapu, Shashi Bhushan, Santosh Kumar Guru, Narsaiah Battini, Ajay Kumar, Sonali S. Bharate and Baljinder Singh. Their work appears in journals such as MedChemComm, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Chemico-Biological Interactions and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.